Valeo Pharmainc (VPH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 01-2022 | 10-2021 | 07-2021 | 04-2021 | 01-2021 | |
| Sales | 4,241 | 3,382 | 5,667 | 2,647 | 1,861 |
| Cost of Goods | 2,832 | 2,682 | 3,506 | 1,938 | 1,476 |
| Gross Profit | 1,409 | 700 | 2,161 | 709 | 385 |
| Operating Expenses | 6,304 | 7,507 | 4,784 | 2,397 | 1,962 |
| Operating Income | -4,895 | -6,807 | -2,623 | -1,688 | -1,577 |
| Interest Expense | 966 | 567 | 435 | 189 | 166 |
| Other Income | -2 | -294 | 84 | 9 | 17 |
| Pre-tax Income | -5,863 | -7,668 | -2,974 | -1,868 | -1,726 |
| Net Income Continuous | -5,863 | -7,668 | -2,974 | -1,868 | -1,726 |
| Net Income | $-5,863 | $-7,670 | $-2,969 | $-1,867 | $-1,726 |
| EPS Basic Total Ops | -0.07 | -0.10 | -0.04 | -0.03 | -0.03 |
| EPS Basic Continuous Ops | -0.07 | -0.10 | -0.04 | -0.03 | -0.03 |
| EPS Diluted Total Ops | -0.07 | -0.10 | -0.04 | -0.03 | -0.03 |
| EPS Diluted Continuous Ops | -0.07 | -0.10 | -0.04 | -0.03 | -0.03 |
| EBITDA(a) | $-4,639 | $-6,857 | $-2,333 | $-1,529 | $-1,417 |